Sunday, November 8, 2026

GBP/EUR Slides By 1% In The Last 21 Sessions

ViaNews Editorial Team

November 21, 2023

GBP/EUR Slides By 1% In The Last 21 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 1.64% for the last 21 sessions. At 00:07 EST on Tuesday, 21 November, GBP/EUR (GBPEUR) is $1.14.

GBP/EUR's yearly highs and lows, it's 2.631% up from its 52-week low and 2.905% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy slides back closer to monthly low amid the emergence of fresh USD selling. According to FXStreet on Monday, 20 November, "In fact, the yield on the benchmark 10-year US government bond fell to a two-month low of 4.379% on Friday, which is holding back the USD bulls from placing aggressive bets and capping the upside for the USD/JPY pair. ", "That said, a generally positive tone around the Asian equity markets could undermine the safe-haven JPY and lend some support to the USD/JPY pair. "
  • Usd/jpy price analysis: moves below 149.00 near six-week lows. According to FXStreet on Monday, 20 November, "The 14-day Relative Strength Index (RSI) below the 50 level signals bearish sentiment, which could inspire the bears of the USD/JPY pair to navigate the support region around 146.50 major level, followed by the 38.2% Fibonacci retracement at 146.37.", "A breakthrough above the latter could support the USD/JPY pair to revisit the previous week's high at 151.90."
  • Usd/jpy analysis: amid profit-taking selling - 20 November 2023. According to DailyForex on Monday, 20 November, "In the long term, and according to the performance on the daily chart, it appears that the USD/JPY is trading within an upward channel. ", "The price of the USD/JPY has now declined, trading several levels below the 100-hour moving average line. "

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com